Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (DRKS00037755) titled 'Identification of predictive and prognostic factors for cell therapy of solid tumors' on Sept. 24.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: Prognosis
Primary Sponsor: Charite - Universitatsmedizin Berlin
Condition:
C43
Malignant melanoma of skin
Intervention:
Group 1: The study includes adult patients (=18 years) with solid tumors, such as melanomas including uveal melanomas, and gynecological tumors (ovarian cancer, endometrial cancer), who show tumor progression after cell therapy and subsequently receive immunotherapy.
Recruitment Status: Recru...